Long before high-tech labs popped up around the globe, medicines like diaveridine hydrochloride started out as real solutions to real problems. Back in the 1950s and 60s, folks in the veterinary world realized coccidiosis was causing big trouble on farms. Looking for reliable tools, chemists began tweaking molecules related to sulfonamides, aiming to trip up the folic acid metabolism of disease-causing bugs. Diaveridine hydrochloride grew out of that practical era. It didn’t arrive as a fancy designer drug, but as a straightforward answer to the growing need for poultry and livestock antibiotics that could outmaneuver resistance and keep animals healthier. There’s not much romance in its origin, just a sense of necessity as communities pushed for medicine that worked outside clinical ivory towers—and that’s often how the best agricultural drugs begin their stories.
Whether in powder form or pressed into tablets, diaveridine hydrochloride lands on a shelf for folks working with animals, not people. It isn’t a magic bullet; it’s a trimethoprim enhancer, teamed up with other antimicrobials for greater bite against infections. Used mostly in livestock and poultry, it deals with diseases tied to E. coli and coccidia. It belongs to the diaminopyrimidine group. The practical folks out in barns and hatcheries have come to trust it as part of a broader cocktail, so to speak, rarely as a standalone remedy. One look at the chemical’s packaging and you can tell it’s built for rugged use, not cosmetic shelf display.
What’s impressive is just how manageable diaveridine hydrochloride feels from the handling perspective. Look at the off-white or yellowish-white powder—a salt form that plays well with water, which matters when mixing large animal doses in feed or water. It fits into everyday life in agriculture: no odd odors, no special temperature controls, and not so finicky that rural folks need a chem degree to work with it. That’s a mark of good drug development. On a molecular level, it resists extreme pH ranges better than older sulfonamides, giving it advantages across all sorts of climates and storage situations, which is a big help on the smallholder farms of my own experience, where nothing stays “just right” for long.
Diaveridine hydrochloride comes with specific labels, but anyone who’s worked with animal meds knows how easy it is to over-complicate with jargon. Reality: bottles display concentration (usually 98-99% pure), warnings about species and withdrawal periods, and suggestions for how much to mix in which context. Labels from different countries give slightly different technical data, but most stick with well-understood instructions designed to avoid running afoul of animal feed regulations or causing accidental overdoses. These rules matter, because every misuse can lead to tough lessons on antibiotic resistance—and nobody needs a resurgence of drug-resistant coccidiosis.
Most manufacturing processes rest on a few tried-and-true reactions. The main trick involves condensation of aromatic aldehydes with guanidine derivatives, then adjusting pH and purifying the salt. I’ve seen older diagrams that look more like a high school chemistry lab than a billion-dollar pharmaceutical plant. That’s by design: easier manufacturing means more countries can participate, reducing dependency on just a handful of big suppliers. Simpler processes also tend to bring down the cost, making it accessible for small producers in emerging economies where larger margins are just not realistic.
Folks in research have spent years trying to find new ways of boosting the molecule’s strength or extending its shelf life—sometimes by modifying functional groups or swapping counter-ions. These changes can have a meaningful impact, like improving solubility for injectable forms. Other scientists focus on creating analogs to combine with sulfonamides for stronger synergy. From all available research, the main principle holds: keep the core structure intact for predictable results, but give some wiggle room for innovation if resistance ticks up. You don’t see a parade of patents here; improvements usually move fast from bench to farm.
Working on several continents, I’ve seen diaveridine hydrochloride listed under half a dozen names—some just slight regional twists on spelling, others entirely different (like Clamoxyl in poultry supplements, though not legally considered an “official” synonym). It also shows up on ingredient sheets co-listed with sulfonamides. A word of warning: always double-check trade names in different locales, because marketing departments tend to invent catchy alternative names for “diaveridine mix” or similar blends. That confusion matters if you’re working in international trade or regulatory compliance.
No chemical in the workplace should be treated as a free pass. That rule never fails. Diaveridine hydrochloride isn't acutely toxic by contact or inhalation in most formulations, but abuse, prolonged exposure, or bad luck can still cause adverse events with skin, eyes, or gut. More than once I’ve seen farmhands treat veterinary drugs with casual disregard, then end up needing a trip to the local clinic. Good gloves, dust masks during mixing, strict labeling, and real training on withdrawal periods are simple steps with huge payoffs. Farmers and drug makers need to take those seriously, because even a minor contamination can have big consequences all the way through the food chain.
Diaveridine hydrochloride anchors a lot of coccidiosis control programs in poultry, supporting a global industry that feeds billions. Its combination with sulfonamides covers a broad range of infections, not just in chickens but in cattle, pigs, and sometimes companion animals. In countries with less restrictive antibiotic rules, it remains widely accessible—sometimes too much so, which fuels debates on resistance management. The drive back and forth between field veterinarians and lab scientists shapes its practical use, especially as diagnostics improve and targeted dosing becomes possible. My own experience says regulatory oversight, not market hype, should guide its use—because ignoring stewardship lessons leads to trouble nobody wants.
Folks across academia and industry remain alert to emerging resistance, and that’s changed how diaveridine hydrochloride gets paired in protocols. Recent studies flag combination therapy as a smart move, especially in regions with documented folate-synthesis resistance genes. A couple of research teams have highlighted the value of ongoing monitoring programs—case counts, resistance tracking, surveillance in wildlife or environmental samples. The best labs focus on next-generation molecules, sometimes tweaking the basic diaminopyrimidine backbone to stretch the timeline before resistance chips away at efficacy. More collaboration between public health authorities and private sector partners has helped push these efforts forward, and funding remains the biggest stumbling block.
Most of the time, diaveridine hydrochloride runs a low risk of acute toxicity when used as directed. But push the dose, or mix it with other veterinary drugs without care, and consequences start adding up. Reports from the field mention bone marrow suppression, especially if dosing errors run for weeks without being caught—something that’s absolutely preventable with practical supervision and better education. Environmental toxicity hasn’t shown up as a widespread problem, though research is ongoing, with new questions about residues in meat and waste runoff. I’ve met more than a few veterinarians who insist on stricter withdrawal periods for all treated stock before slaughter, and it’s hard to argue with that level of caution.
Standing at the crossroads of tradition and innovation, diaveridine hydrochloride faces fresh challenges each year. Global pushback on indiscriminate antibiotic use has already spurred some countries to restrict or phase out older broad-spectrum compounds. For the foreseeable future, this molecule will keep filling a crucial gap—especially in places where high-tech solutions move slowly or cost too much for small producers. The future leans on smarter stewardship, deeper investment in molecular research, and clearer communication up and down the supply chain. With increased scrutiny and public concern around animal medicines, the industry can adopt reforms that protect both animal health and market sustainability, blending lessons from decades of tried-and-true use with the speed of modern data and agricultural science.
Many folks outside agriculture may not recognize the name diaveridine hydrochloride, but it stands behind some of the toughest defenses in animal health. This synthetic compound shows up not in household medicine cabinets, but in vet offices and feedlots, where it serves a modest but vital purpose: fighting infections in animals. Watching how sick poultry and livestock respond to treatment underscores why drugs like this matter, especially in places where an outbreak can destroy farmer livelihoods in a season.
Diaveridine hydrochloride goes right after protozoan parasites. These tiny troublemakers attack the digestive tract of birds—think chickens, turkeys, ducks—as well as some farm mammals. Coccidiosis, caused by Eimeria parasites, loves crowded barns and warm weather, and just a few cases can quickly become an epidemic.
Here’s how diaveridine hydrochloride works. It shuts down an enzyme called dihydrofolate reductase. By blocking this enzyme, the drug halts the production of folic acid in the parasites, and without folic acid they lose their ability to multiply and thrive. Meanwhile, the host animal can recover, eat, and gain weight. Many vets pair diaveridine with sulfonamide drugs. This combination creates a one-two punch that knocks out parasites more effectively, especially because the two compounds block folic acid production at different points. No single medicine does the job alone anymore—parasites evolve fast, and relying on just one treatment risks breeding resistance.
One overlooked fact is the ripple effect that animal disease can have on the food chain and rural incomes. In areas where families depend on animal protein and milk, even minor outbreaks drag down food quality and farm profits. Diaveridine hydrochloride, in its role as part of a broader treatment plan, helps keep animals healthy so farms can deliver enough food to markets. According to research published in the Journal of Veterinary Pharmacology and Therapeutics, losses from coccidiosis alone rack up billions of dollars worldwide every year, mostly from lower weight gain and higher feed costs.
Resistance remains the biggest shadow over drug-based treatments. After decades of use, some Eimeria strains have grown tougher. That means more attention has shifted toward smart use—rotating medications, using vaccinations when possible, and keeping coops clean. Personally, I’ve seen farms where heavy-handed use of anticoccidials led to resistant strains that wouldn’t budge, even with high doses. Listening to local vets, who watch patterns in parasite outbreaks, makes a bigger difference than waiting for symptoms to explode.
Diaveridine hydrochloride covers an important base—buying time for animals to recover, and for farmers to breathe easier. Today’s best practice focuses on targeted use, not carpet-bombing every bird on a farm. Combining strategies, such as rotating drugs every few cycles, changing feed, and giving animals room to move, lowers sickness rates and keeps medicines like diaveridine effective. For now, diaveridine hydrochloride remains in the medicine chest, relied upon not just for keeping animals alive, but for keeping food systems steady and affordable for everyone.
Diaveridine Hydrochloride gets used mostly for treating infections in animals, but people studying medicine often ask about its risks. This drug usually works as an antibacterial agent, combined with sulfonamides, to stop the growth of bacteria. Reports show animals can face some uncomfortable issues, and since drug safety for humans is always a question, looking at these concerns cuts straight to the point.
Digestive discomfort stands out the most. Animals given Diaveridine Hydrochloride sometimes develop a poor appetite, loose stools, bloating, or even vomiting. These signs point to disturbances in the gut’s natural balance. The pressure on the digestive system often links back to the way medicines attack bacteria, wiping out some beneficial ones along with the harmful sort.
Skin problems pop up every now and then. Rashes, itchiness, or swelling have all been noted by veterinarians. Allergic reactions play a part here, and the triggers aren’t always obvious. If you have ever watched a pet scratch or develop red patches after medication, you know it worries owners and doctors alike.
Medications the body sees as foreign usually pass through the liver and kidneys before leaving the body. Diaveridine Hydrochloride can put some stress on both. Researchers studying prolonged or high-dose use found that these organs sometimes suffer inflammation or damage. Toxins build up if the liver can’t break things down fast enough, or if the kidneys struggle to keep up. Blood work in animals can show changes in liver enzymes or kidney markers, which pushes doctors to check these levels carefully during treatment.
There are a few cases where Diaveridine Hydrochloride changed the makeup of blood. Specifically, low white blood cell counts have been spotted. This leaves the animal, or potentially a person, more open to infection. A weakened immune response is never welcome, especially in a body already fighting illness.
Less common but very serious, some animals developed signs of anemia. Red blood cell levels dropped, likely because the bone marrow got affected. A tired, weak pet or a patient struggling for breath reminds us of just how interconnected the body’s systems are.
Overusing antibacterial agents feeds into another issue: drug resistance. The more often Diaveridine Hydrochloride or similar drugs hit bacteria, the higher the chance those bacteria get smarter. They change and adapt, making future infections harder to treat. This isn’t a problem exclusive to this drug, but it’s a shadow hanging over all antibiotic use. Surveys of farms and veterinary records show resistance patterns changing across regions, reminding us to handle drug use responsibly.
Every medicine comes with a trade-off, so balancing benefits against side effects matters. Careful dosing and short treatment windows help lower the risk, as does regular testing of liver and kidney function. Veterinarians stick to withdrawal times in food-producing animals, avoiding drug residues in meat, eggs, or milk. Educating pet owners and farmers keeps everyone in the loop about what signs to watch for and what to do if trouble shows up.
Research keeps rolling forward. New methods for monitoring drug levels, genetic testing for sensitivities, and even targeted probiotics all add pieces to the safety puzzle. Open conversations between doctors, patients, and the wider community make the difference, making sure the focus stays on both animal health and long-term safety for all.
Getting the dosage right makes all the difference between treatment and trouble. Diaveridine Hydrochloride, an old staple among veterinarians, treats infections in animals caused by bacteria and certain protozoa. Yet, not every animal handles medicine the same way. Too little, and you don’t see a change; too much, and you might create a bigger problem—sometimes worse than the original illness.
Veterinary textbooks and the World Health Organization have listed common dose ranges for Diaveridine Hydrochloride. For poultry, cattle, sheep, pigs, and rabbits, you’ll usually find oral doses between 5 to 10 mg per kilogram of body weight per day. Treatment length runs from three to five days. Working with birds and livestock, I’ve seen farmers prefer to level out dosing over the day, often mixing with feed or water for the sake of simplicity and consistency. The way the medicine is delivered does affect how well it works, so clean water and proper mixing always matter.
Underdosing doesn’t just waste money—it helps build antimicrobial resistance. Overdosing, on the other hand, risks toxicity, and the signs aren’t pretty: loss of appetite, sluggishness, or even collapse in severe cases. Not all side effects show up right away. I’ve known ranchers who watched their animals grow weak weeks after the shortest course.
A shape-shifting problem with Diaveridine and similar drugs is residue in animal products. If you don’t honor proper withdrawal periods—usually around 5 to 7 days after the last dose—consumers get low-level exposure to chemicals, undermining food safety. Detection of residues in eggs, milk, or meat can wipe out a farmer’s profit for a season. Data from food safety agencies backs this up, as residue problems still score among the top causes for product recalls.
Online forums offer quick answers but rarely the right ones. Dosing should factor in the animal’s age, weight, health condition, and any co-infections present, plus other medications in use. Some breeds and younger animals react differently. I’ve seen owners lose stock, not to disease, but to home-administered, poorly calculated doses.
A competent veterinarian who knows the latest on drug resistance and has a grip on current outbreaks can guide you to the proper use of Diaveridine. They might suggest supportive therapies—plenty of fluids, probiotics, or dietary tweaks—so animals recover faster and stay productive. In my experience, local vets have saved more flocks than any internet “wisdom.”
Always weigh animals rather than eyeballing. Stick to trusted, labeled products and avoid splitting up bulk powder without the right tools. Track each treatment in a record book and follow up with your vet before stopping a course early. Rushing recovery often sets up repeated cycles of illness and half-baked cures that don't fix the main issue.
Everyone wants a quick fix. Relying on set doses from memory or old habits rarely lines up with the tough realities on farms or backyard coops. Responsible dosing protects animals, the people who eat animal products, and the future usefulness of Diaveridine Hydrochloride in livestock health.
Diaveridine Hydrochloride pops up in conversations about veterinary drugs, especially among farmers and veterinarians working with livestock. On the farm, this compound works as an antimicrobial and is often paired with sulfonamides to fight off infections in poultry and other animals. When birds or animals show signs of bacterial infections, a mix like this often turns the tide. Some folks ask if the treatment goes beyond the barn and carries any weight for human health. Questions about safety linger long after the feed has been mixed or the pills handed out.
Most veterinarians trust Diaveridine Hydrochloride because research and real-world use show clear benefits. Chickens suffering from coccidiosis—one of the nastiest gut infections—often bounce back after a treatment cycle that blends this drug with sulfonamides. Health officials in several countries have allowed its use in animal medicine because studies tracked results and looked for side effects. They found that when animals get the proper dose for the right period, outcomes usually leave little to worry about. Overdosing or ignoring withdrawal times brings trouble, though. I remember one old neighbor who rushed to market with eggs before the withdrawal period ran out. The result? His whole batch was tossed due to residue levels exceeding safety limits. Sticking to guidelines protects everyone.
Issues start appearing if someone skips instructions or uses more than directed. Animals can experience side effects like loss of appetite or diarrhea if the balance isn’t right. For humans, the bigger story centers on residues. If traces remain in meat, eggs, or milk after animals have been treated, consumers could face problems. Allergic reactions pop up now and then, especially with the sulfonamide mix. Bathroom reading, including reports from regulatory agencies, outlines risks such as the potential for resistance among bacteria. Antibiotic resistance isn’t just a buzzword; I’ve seen farmers struggle to control outbreaks because bacteria learned to shrug off older meds, likely from overuse or shortcuts.
Food safety regulators track levels of Diaveridine Hydrochloride in products. Official limits lie at the heart of keeping food safe for the public. The World Health Organization and food safety authorities, including the FDA and EFSA, point out that following recommended guidelines protects consumers. I’ve heard more than one farm inspector say that spot checks for residues lead to temporary farm closures if standards slip. Regulatory files point to adverse outcomes in cases where guidelines get thrown out the window.
Tracking and labeling systems could improve confidence in the products reaching our tables. More education for both farmers and consumers would help. I remember a vet teaching a group of us about safe withdrawal times and saw how that short session saved future headaches. Encouraging the use of alternatives and investing in research may lower the need for compounds like Diaveridine Hydrochloride. Keeping open records and pushing for updates based on new science builds trust. Real-life stories, not just lab results, highlight the stakes for families, farmers, and the folks who depend on them for safe food.
Every time I talk with folks who work in veterinary clinics or on farms, safe medicine storage comes up fast. Diaveridine Hydrochloride plays a big role in keeping animals healthy, especially in fighting infections when mixed with other drugs. Proper storage helps guard against wasted money, lost time, and health risks for people and livestock.
A lot of people ignore humidity until things start clumping or losing effectiveness. Diaveridine Hydrochloride picks up moisture in damp air. That can wreck quality. Every bottle or container should live on a shelf, away from sinks or open windows. Temperature jumps also cause trouble—avoid putting it near heaters, radiators, or in direct sunlight.
Stories float around about pet accidents and kids in barns getting into medicines. Simple clear labeling and a solid locking cabinet keep this powder out of the wrong hands. Bright, clear labels save lives and stop dumb mistakes.
My grandfather believed everything belonged in glass, especially chemicals. That tradition holds water for some vet drugs, but the label on Diaveridine Hydrochloride bottles usually gives the best advice. Some plastics don’t stand up to light or long storage, but glass keeps moisture out better. Always follow the packaging guide from the manufacturer.
Too many barns and clinics hold onto half-used stocks because tossing them out feels like waste. The truth—expired Diaveridine Hydrochloride can become weaker or even risky. Written policies in vet clinics help keep shelves cleared of outdated product. Using a “first in, first out” approach makes sure nobody grabs a powder that’s been sitting for ages.
Once, on a small farm, a well-meaning caretaker kept livestock antibiotics in a warm, sometimes damp feed room. They discovered clumps and odd smells, plus a rise in animal sickness. Lab tests showed the medicine lost strength. Health experts link poor storage to drug resistance and lost livestock. No one wants to risk that, especially when simple effort would prevent it.
Training is key—make sure everyone who handles vet drugs knows the risks of poor storage. Keep written reminders around cupboards and clear instructions near every medicine shelf. Check inventory often and toss anything that looks or smells off. Electronic logs track temperatures for larger clinics and flag warning signs early.
Every bag or bottle of Diaveridine Hydrochloride represents trust—trust that medicine will do its job and animals will heal. It’s not just about following rules. It’s about keeping everyone safe, keeping animals healthy, and saving money in the long run. A few minutes spent organizing storage pays off daily, with far fewer headaches and no tragic surprises.
| Names | |
| Preferred IUPAC name | 4-[(3,4-Dimethoxyphenyl)methyl]-2,6-pyrimidinediamine hydrochloride |
| Other names |
Diaveridine Hydrochloride 4,6-Diamino-2,2-dimethylpyrimidine hydrochloride 4,6-Diamino-2,2-dimethylpyrimidine monohydrochloride |
| Pronunciation | /daɪˌævəˈraɪdiːn haɪˌdrɒklaɪd/ |
| Identifiers | |
| CAS Number | '5355-16-8' |
| 3D model (JSmol) | `3D model (JSmol)` string for **Diaveridine Hydrochloride**: ``` CC1=NC(=NC(=N1)N)NC2=CC=C(C=C2)OC.Cl ``` This is the **SMILES** string representing the molecular structure, suitable for use in JSmol or similar molecular viewers. |
| Beilstein Reference | 2126702 |
| ChEBI | CHEBI:9468 |
| ChEMBL | CHEMBL295513 |
| ChemSpider | 20296772 |
| DrugBank | DB13270 |
| ECHA InfoCard | 100.035.334 |
| EC Number | 259-554-9 |
| Gmelin Reference | 80864 |
| KEGG | D08347 |
| MeSH | D03.438.505.139.180.407.220 |
| PubChem CID | 3033987 |
| RTECS number | XJ8225000 |
| UNII | W34IUR7V78 |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DB11978 |
| Properties | |
| Chemical formula | C13H16N4O2·HCl |
| Molar mass | 303.22 g/mol |
| Appearance | white or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.38 g/cm3 |
| Solubility in water | Freely soluble in water |
| log P | -0.55 |
| Acidity (pKa) | 6.9 |
| Basicity (pKb) | 6.28 |
| Magnetic susceptibility (χ) | -59.0 × 10⁻⁶ cm³/mol |
| Dipole moment | 2.98 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 321.7 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | QJ01EW05 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin and eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Harmful if swallowed. Causes serious eye irritation. |
| Precautionary statements | Wash thoroughly after handling. Avoid breathing dust/fume/gas/mist/vapours/spray. Use only outdoors or in a well-ventilated area. IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. |
| Flash point | 75.1°C |
| Lethal dose or concentration | LD₅₀ (mouse, oral): 5900 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Diaveridine Hydrochloride: 630 mg/kg (oral, mouse) |
| NIOSH | SN3500000 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 20-50 mg per kg body weight |
| Related compounds | |
| Related compounds |
Trimethoprim Pyrimethamine Ormetoprim Methotrexate |